Main > ONCOLOGY (**) > Lung>NSCLC>MET>NRG1+ > TREAT > NL. M. Biclonics® Technology

---

NL. M. Biclonics® Technology's subsections
(*) USA Approval Date: 2024. 12.04
Company
RTM
RTM Web-Site
WIPO Patent Numbers

NL. M. Biclonics® Technology's products
This section has no products